Category: Laboratory Instruments
Laboratory Instruments
Holliston, Mass.-based scientific instrument maker Harvard Bioscience launches a bioreactor as it looks to enter the regenerative medicine market.
When surgeons in Spain successfully replaced a young woman's trachea in 2008, using a tissue-engineered windpipe researchers had grown out of her own stem cells, the world took notice.
David Green, the president of Harvard Bioscience Inc. (NSDQ:HBIO), a Holliston, Mass.-based lab instruments maker, also noticed. Green picked up the phone to call Italy shortly after the news hit the wires; this week the company launched a commercial version of the bioreactor researchers used to grow the bronchus, the ORGANIZER Series Model 100 "In Breath" bioreactor.
Billerica, Mass.-based scientific instrument maker Bruker Corp. snags three divisions of the Palo Alto, Calif.-based instruments company after Agilent is forced to divest the businesses to comply with European anti-trust laws.
Agilent Technologies Inc.'s (NYSE:A) embarrassment of riches turned out to be a boon for Bruker Corp. (NSDQ:BRKR) too.
The companies announced the completion of a deal to sell Billerica, Mass.-based Bruker three business units of Varian Inc. so Agilent can comply with European anti-trust laws. Agilent
acquired its Palo, Alto, Calif.-based instrument-making subsidiary in July 2009 for a reported $1.5 billion.
Caliper Life Sciences Inc. posts fourth-quarter profits on a 3 percent uptick in revenues, beating its own guidance for the quarter.
Caliper Life Sciences Inc. (NSDQ:CALP) made progress on the path to profitability during the fourth quarter, posting net income for the first time during 2009 and beating its previous revenue guidance by $1 million.
The Hopkinton, Mass.-based lab equipment and services provider posted revenues of $37.7 million during the three months ended Dec. 31, 2009, up 2.6 percent compared with $36.7 million during the same period in 2008. That's about $1 million more than predicted; in January, the company said it expected to post $36.7 million in sale for the quarter.
Microfluidics International names a pair of new board members: former Boston Scientific VP Henry Kay and Stephen Robinson of Sigma Aldrich.
Microfluidics International Corp. (OTC:MFLU) named two new members to its board of directors, a former Boston Scientific Corp. (NYSE:BSX) executive and the former CEO of Epichem Inc., now a Sigma Aldrich subsidiary.
The Newton, Mass.-based manufacturer of material-processing tools said it tapped Henry Kay and Stephen Robinson for its board. Kay has a 35-year history in the medical industry, with stints at Schering-Plough, Allergan Europe and American Home Products. His last stop was at Boston Scientific, where he was group vice president for new market development and strategic planning in the endosurgery division. Kay, who retired from BSX in 2006, is the U.S. partner of Medica Venture Partners, a healthcare VC firm based in Israel.
A warning that a faulty rotor on centrifuges made by Westwood, Mass.-based IRIS Sample Processing could break and cause serious injury.
The New England district office of the Food & Drug Administration issued a Class 1 recall notice for the StatSpin Express 4 Centrifuges, a product that rapidly separates blood cells from plasma, made by IRIS Sample Processing.
The problem is based in a faulty rotor that can break and cause a chain reaction, according to
a recall notice issued Jan. 27.
Holliston, Mass.-based lab instruments maker Harvard Bioscience sees 20 percent growth in sales during the fourth quarter, paced by its acquisition of Denville Scientific Inc.
Harvard Bioscience Inc. (NSDQ:HBIO) is seeing some returns from its $24 million acquisition of Denville Scientific Inc.
The Holliston, Mass.-based lab instruments maker said revenues from its new Denville subsidiary contributed $5.7 million in sales during the three months ended Dec. 31, 2009. In all, revenues from Denville made up about 20 percent of the $27.6 million in sales the company reported during the quarter; during the same period last year the company posted $23 million in sales.
Thermo Fisher Scientific Inc. finalizes its buyout of handheld spectrometer maker Ahura Scientific.
Amid reports that it's a major player in the $6 billion Millipore Corp. (NYSE:MIL) sweepstakes, Thermo Fisher Scientific Inc. (NYSE:TMO) finished up a slightly smaller deal by closing its acquisition of Ahura Scientific.
The Waltham, Mass.-based lab equipment and services provider said in January that it had agreed to acquire Ahura for $145 million in cash plus a possible earn-out payment if Ahura meets certain 2010 financial targets. Ahura makes portable chemical detection devices designed for use outside of the lab.
